CN115363130A - 一种解酒护肝方糖及其应用 - Google Patents
一种解酒护肝方糖及其应用 Download PDFInfo
- Publication number
- CN115363130A CN115363130A CN202211022565.0A CN202211022565A CN115363130A CN 115363130 A CN115363130 A CN 115363130A CN 202211022565 A CN202211022565 A CN 202211022565A CN 115363130 A CN115363130 A CN 115363130A
- Authority
- CN
- China
- Prior art keywords
- liver
- parts
- protecting
- sugar
- alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000000346 sugar Nutrition 0.000 title claims abstract description 50
- 206010019133 Hangover Diseases 0.000 claims abstract description 20
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 17
- 238000003756 stirring Methods 0.000 claims abstract description 16
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 14
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 14
- 238000002156 mixing Methods 0.000 claims abstract description 14
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 claims abstract description 13
- 235000021552 granulated sugar Nutrition 0.000 claims abstract description 13
- 239000000843 powder Substances 0.000 claims abstract description 13
- 230000002075 anti-alcohol Effects 0.000 claims abstract description 12
- 241000208140 Acer Species 0.000 claims abstract description 11
- 238000002360 preparation method Methods 0.000 claims abstract description 10
- 241000219781 Pueraria montana var. lobata Species 0.000 claims abstract description 9
- 150000003272 mannan oligosaccharides Chemical class 0.000 claims abstract description 9
- 239000000203 mixture Substances 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 206010067125 Liver injury Diseases 0.000 claims abstract description 6
- 230000001476 alcoholic effect Effects 0.000 claims abstract description 6
- 238000001816 cooling Methods 0.000 claims abstract description 6
- 231100000753 hepatic injury Toxicity 0.000 claims abstract description 6
- 238000010298 pulverizing process Methods 0.000 claims abstract description 6
- 238000007873 sieving Methods 0.000 claims abstract description 6
- 238000010438 heat treatment Methods 0.000 claims abstract description 5
- 210000004185 liver Anatomy 0.000 claims description 29
- 208000007848 Alcoholism Diseases 0.000 claims description 15
- 201000007930 alcohol dependence Diseases 0.000 claims description 15
- 230000002443 hepatoprotective effect Effects 0.000 claims description 5
- 208000024891 symptom Diseases 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 24
- 230000000694 effects Effects 0.000 abstract description 16
- 230000035622 drinking Effects 0.000 abstract description 5
- 235000013305 food Nutrition 0.000 abstract description 3
- 230000000857 drug effect Effects 0.000 abstract description 2
- 239000000126 substance Substances 0.000 description 12
- 241000699670 Mus sp. Species 0.000 description 10
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 8
- 244000046146 Pueraria lobata Species 0.000 description 8
- 210000001035 gastrointestinal tract Anatomy 0.000 description 7
- 210000005229 liver cell Anatomy 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 108010081577 aldehyde dehydrogenase (NAD(P)+) Proteins 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 210000004969 inflammatory cell Anatomy 0.000 description 5
- 239000013642 negative control Substances 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- 210000003855 cell nucleus Anatomy 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 2
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000028527 righting reflex Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000004916 vomit Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- -1 amino oligosaccharide Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000036983 biotransformation Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 102000036209 mannose binding proteins Human genes 0.000 description 1
- 108020003928 mannose binding proteins Proteins 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 235000018648 unbalanced nutrition Nutrition 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/42—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Organic Chemistry (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211022565.0A CN115363130B (zh) | 2018-07-10 | 2018-07-10 | 一种解酒护肝方糖及其应用 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211022565.0A CN115363130B (zh) | 2018-07-10 | 2018-07-10 | 一种解酒护肝方糖及其应用 |
CN201810750187.5A CN109007213A (zh) | 2018-07-10 | 2018-07-10 | 一种解酒护肝方糖及其制备方法 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810750187.5A Division CN109007213A (zh) | 2018-07-10 | 2018-07-10 | 一种解酒护肝方糖及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115363130A true CN115363130A (zh) | 2022-11-22 |
CN115363130B CN115363130B (zh) | 2024-04-30 |
Family
ID=64641549
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211022565.0A Active CN115363130B (zh) | 2018-07-10 | 2018-07-10 | 一种解酒护肝方糖及其应用 |
CN201810750187.5A Pending CN109007213A (zh) | 2018-07-10 | 2018-07-10 | 一种解酒护肝方糖及其制备方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810750187.5A Pending CN109007213A (zh) | 2018-07-10 | 2018-07-10 | 一种解酒护肝方糖及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN115363130B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106135615A (zh) * | 2016-06-27 | 2016-11-23 | 云南省农业科学院甘蔗研究所 | 一种葛根糖的生产方法 |
CN106235327A (zh) * | 2016-07-14 | 2016-12-21 | 万光瑞 | 一种适时解酒、护胃、护肝、护脑组合物及其应用 |
CN107494871A (zh) * | 2017-09-05 | 2017-12-22 | 刘爱民 | 一种解酒的枳椇子壳寡糖压片糖果 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100539877C (zh) * | 2005-07-05 | 2009-09-16 | 黄恒燊 | 解酒保肝饮料及其制备方法 |
CN104286842A (zh) * | 2014-09-12 | 2015-01-21 | 刘益君 | 一种解酒护肝的复方组合片 |
CN104351610B (zh) * | 2014-10-23 | 2019-08-09 | 吉林省现代中药工程研究中心有限公司 | 一种抑制酒精吸收、促进酒精代谢的保健口服液及制备方法 |
CN105029425A (zh) * | 2015-01-24 | 2015-11-11 | 郑州博凯医药保健品有限公司 | 乳糖果酸解酒护肝泡腾片 |
CN106616174A (zh) * | 2016-10-14 | 2017-05-10 | 高比(厦门)食品有限公司 | 解酒护肝固体饮料及其制备方法 |
CN107348299A (zh) * | 2017-07-31 | 2017-11-17 | 湖州金诺康健康科技有限公司 | 一种具有护肝解酒功效的固体饮料 |
CN111990520A (zh) * | 2020-09-12 | 2020-11-27 | 南京滇浩光医学科技有限公司 | 一种促进酒精代谢、保护肝脏的组合物及其应用 |
-
2018
- 2018-07-10 CN CN202211022565.0A patent/CN115363130B/zh active Active
- 2018-07-10 CN CN201810750187.5A patent/CN109007213A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106135615A (zh) * | 2016-06-27 | 2016-11-23 | 云南省农业科学院甘蔗研究所 | 一种葛根糖的生产方法 |
CN106235327A (zh) * | 2016-07-14 | 2016-12-21 | 万光瑞 | 一种适时解酒、护胃、护肝、护脑组合物及其应用 |
CN107494871A (zh) * | 2017-09-05 | 2017-12-22 | 刘爱民 | 一种解酒的枳椇子壳寡糖压片糖果 |
Also Published As
Publication number | Publication date |
---|---|
CN109007213A (zh) | 2018-12-18 |
CN115363130B (zh) | 2024-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104351586A (zh) | 一种牛配合饲料及其制备方法 | |
CN110643524B (zh) | 一种具有胃肠道粘膜保护作用的复合益生菌制剂及其应用 | |
CN104068279B (zh) | 一种含有中药添加剂的鳗鱼饲料及其制备方法 | |
CN107348521B (zh) | 具有改善胃肠道功能的中药复合肽组合物及其制备方法 | |
CN106578801A (zh) | 一种具有降糖作用的综合酵素粉及其制备方法 | |
CN107440107A (zh) | 一种供妊娠反应人群食用含短肽的特殊膳食用食品配方 | |
CN102696928A (zh) | 用于治疗猪流感的饲料、中药组合物、制备方法和应用 | |
CN111642614A (zh) | 一种解酒的压片糖果及其制备方法 | |
CN108324921B (zh) | 一种具有祛除囊肿、保护胃粘膜功能的药物组合物及其制备方法 | |
CN113413454A (zh) | 一种促进胃粘膜损伤修复的组合物及其制备方法 | |
CN104839685A (zh) | 创伤感染手术及其它应急状态医学配方食品 | |
CN115363130B (zh) | 一种解酒护肝方糖及其应用 | |
CN102920717A (zh) | 水苏糖在解酒方面的应用 | |
CN110801488B (zh) | 一种调节脑肠轴多糖组合益生元颗粒及制备方法和应用 | |
CN107467654B (zh) | 一种海带海参复合提取物及其制备方法和应用 | |
CN109674060B (zh) | 一种具有辅助缓解二型糖尿病功能的益生菌膳食补充剂及其应用 | |
CN105614124A (zh) | 添加中药成分和微生物制剂的提高产蛋量的鸡饲料 | |
CN113116941A (zh) | 一种可缓解2型糖尿病的益生菌、益生元复合制剂及其制备方法 | |
CN103690878A (zh) | 一种护理治疗胃肝的中药配方 | |
KR101093006B1 (ko) | 미생물을 이용한 우황 청심원 원료 함유 건강식품의 제조방법 및 그 제조방법에 의해 제조된 건강식품 | |
CN111084878A (zh) | 一种用于肺及呼吸系统疾病的生物医药、医用全营养食品及制备方法 | |
CN104996991A (zh) | 红斑狼疮医学配方食品 | |
CN114129692B (zh) | 一种治疗疖病的中药组合物及其制备方法与应用 | |
CN111265627B (zh) | 一种调节肠道菌群的海参多糖组合物及其制备方法和应用 | |
CN113100342A (zh) | 一种用于促进仔猪生长的添加剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20240403 Address after: 266000 2 / F, 3 / F, 4 / F, block A1, 1 Jinye Road, high tech Industrial Development Zone, Qingdao City, Shandong Province Applicant after: QINGDAO MINGYAOTANG MEDICAL CO.,LTD. Country or region after: China Address before: 266113 room 503, administrative committee building of Qingdao export processing zone, Hongdao Economic Zone, Qingdao, Shandong Province Applicant before: QINGDAO HIGH-TECH ZONE SHANGDA PHARMACEUTICAL Research Institute Country or region before: China |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |